0001209191-21-069638.txt : 20211214 0001209191-21-069638.hdr.sgml : 20211214 20211214200230 ACCESSION NUMBER: 0001209191-21-069638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211210 FILED AS OF DATE: 20211214 DATE AS OF CHANGE: 20211214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY MARY ANN CENTRAL INDEX KEY: 0001261974 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 211492583 MAIL ADDRESS: STREET 1: 201 W 70TH ST, SUITE 23K CITY: NEW YORK STATE: NY ZIP: 10023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-10 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001261974 GRAY MARY ANN 215 FIRST STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2021-12-10 4 M 0 967 0.00 A 9403 D Restricted Stock Units 2021-12-10 4 M 0 967 0.00 D 2021-12-10 Common Stock 967 0 D Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock. The third out of three annual equal installments of restricted stock units vested on December 10, 2021. /s/ Ryan Brown, as Attorney-in-Fact for Mary Ann Gray 2021-12-14